Association between quantitative parameters of CEUS and Sall4/Wnt/β-catenin signaling in patients with hepatocellular carcinoma

References

• Sia D, Villanueva A, Friedman SL, Llovet JM. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology. 2017;152(4):745–761. doi:10.1053/j.gastro.2016.11.04828043904
   PubMed Web of Science ®Google Scholar
• Villanueva A, Llovet JM. Liver cancer in 2013: mutational landscape of HCC–the end of the beginning. Nat Rev Clin Oncol. 2014;11(2):73–74. doi:10.1038/nrclinonc.2013.24324395088
   PubMed Web of Science ®Google Scholar
• Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149(5):1226–1239. doi:10.1053/j.gastro.2015.05.06126099527
   PubMed Web of Science ®Google Scholar
• Jones B. Liver cancer: SALL4–a cancer marker and target. Nat Rev Clin Oncol. 2013;10(8):426. doi:10.1038/nrclinonc.2013.112
   PubMedGoogle Scholar
• Yin F, Han X, Yao SK, Wang XL, Yang HC. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. World J Gastroenterol. 2016;22(9):2837–2843. doi:10.3748/wjg.v22.i9.283726973422
   PubMed Web of Science ®Google Scholar
• Fan H, Cui Z, Zhang H, et al. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with hepatitis B or C virus infection. Oncogene. 2016;36(17):2435–2445. doi:10.1038/onc.2016.399
   Google Scholar
• Han SX, Wang JL, Guo XJ, et al. Serum SALL4 is a novel prognosis biomarker with tumor recurrence and poor survival of patients in hepatocellular carcinoma. J Immunol Res. 2014;2014:262385. doi:10.1155/2014/39412724860834
   PubMed Web of Science ®Google Scholar
• Shuai X, Zhou D, Shen T, et al. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes. Cancer Genet Cytogenet. 2009;194(2):119–124. doi:10.1016/j.cancergencyto.2009.06.00619781444
   PubMedGoogle Scholar
• Ma Y, Cui W, Yang J, et al. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood. 2006;108(8):2726–2735. doi:10.1182/blood-2006-02-00159416763212
   PubMed Web of Science ®Google Scholar
• He J, Zhou M, Chen X, et al. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/beta-catenin pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2016;35(1):98. doi:10.1186/s13046-016-0444-627329034
   PubMedGoogle Scholar
• Zhu L, Huang F, Deng G, et al. Knockdown of Sall4 inhibits intrahepatic cholangiocarcinoma cell migration and invasion in ICC-9810 cells. Onco Targets Ther. 2016;9:5297–5305. doi:10.2147/OTT.S10721427601921
   PubMed Web of Science ®Google Scholar
• Bo XW, Xu HX, Wang D, et al. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers. Br J Radiol. 2016;89(1067):20160379. doi:10.1259/bjr.2016037927626506
   PubMed Web of Science ®Google Scholar
• Takada H, Tsuchiya K, Yasui Y, et al. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Cancer Med. 2016;5(11):3111–3120. doi:10.1002/cam4.93227748052
   PubMed Web of Science ®Google Scholar
• Liu W, Xiao P, Wu H, et al. MicroRNA-98 plays a suppressive role in non-small cell lung cancer through inhibition of SALL4 protein expression. Oncol Res. 2016;25(6):975–988. doi:10.3727/096504016X14791726591124
   Google Scholar
• Tian Q, Xiao Y, Wu Y, et al. MicroRNA-33b suppresses the proliferation and metastasis of hepatocellular carcinoma cells through the inhibition of Sal-like protein 4 expression. Int J Mol Med. 2016;38(5):1587–1595. doi:10.3892/ijmm.2016.275428026002
   PubMed Web of Science ®Google Scholar
• Dirican E, Akkiprik M. Functional and clinical significance of SALL4 in breast cancer. Tumour Biol. 2016;37(9):11701–11709. doi:10.1007/s13277-016-5150-727444278
   PubMedGoogle Scholar
• Yong KJ, Li A, Ou WB, et al. Targeting SALL4 by entinostat in lung cancer. Oncotarget. 2016;7(46):75425–75440. doi:10.18632/oncotarget.1225127705911
   PubMedGoogle Scholar
• Yuan X, Zhang X, Zhang W, et al. SALL4 promotes gastric cancer progression through activating CD44 expression. Oncogenesis. 2016;5(11):e268. doi:10.1038/oncsis.2016.6927819668
   PubMedGoogle Scholar
• Zhou S, Venkatramani R, Gomulia E, Shillingford N, Wang L. The diagnostic and prognostic value of SALL4 in hepatoblastoma. Histopathology. 2016;69(5):822–830. doi:10.1111/his.1300527252091
   PubMed Web of Science ®Google Scholar
• Hao L, Zhao Y, Wang Z, et al. Expression and clinical significance of SALL4 and beta-catenin in colorectal cancer. J Mol Histol. 2016;47(2):117–128. doi:10.1007/s10735-016-9656-526779651
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu Y, Cheng W, Liu X. Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms. Oncol Lett. 2016;12(5):3763–3770. doi:10.3892/ol.2016.520627895728
   PubMed Web of Science ®Google Scholar
• Zheng W, Xiong YH, Han J, et al. Contrast-enhanced ultrasonography of cervical carcinoma: perfusion pattern and relationship with tumour angiogenesis. Br J Radiol. 2016;89(1065):20150887. doi:10.1259/bjr.2015088727340932
   PubMed Web of Science ®Google Scholar
• Wang J, Lv F, Fei X, et al. Study on the characteristics of contrast-enhanced ultrasound and its utility in assessing the microvessel density in ovarian tumors or tumor-like lesions. Int J Biol Sci. 2011;7(5):600–606.21614152
   PubMed Web of Science ®Google Scholar
• Tian H, Wang Q. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound. Eur J Cancer. 2016;68:82–89. doi:10.1016/j.ejca.2016.08.01627728840
   PubMed Web of Science ®Google Scholar